These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 879738)

  • 21. Studies on the biosynthesis of clavulanic acid. I. Incorporation of 13C-labelled precursors.
    Elson SW; Oliver RS
    J Antibiot (Tokyo); 1978 Jun; 31(6):586-92. PubMed ID: 681240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-lactamase stability of faropenem.
    Dalhoff A; Nasu T; Okamoto K
    Chemotherapy; 2003 Sep; 49(5):229-36. PubMed ID: 14504433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and property of beta-lactamases in Streptomyces.
    Ogawara H
    Antimicrob Agents Chemother; 1975 Oct; 8(4):402-8. PubMed ID: 242252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naturally-occurring beta-lactamase inhibitors with antibacterial activity.
    Brown AG; Butterworth D; Cole M; Hanscomb G; Hood JD; Reading C; Rolinson GN
    J Antibiot (Tokyo); 1976 Jun; 29(6):668-9. PubMed ID: 950324
    [No Abstract]   [Full Text] [Related]  

  • 25. R-factor mediated beta-lactamase production by Haemophilus influenzae.
    Sykes RB; Matthew M; O'Callaghan CH
    J Med Microbiol; 1975 Aug; 8(3):437-41. PubMed ID: 1080810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
    Paisley JW; Washington JA
    Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timentin and beta-lactamases.
    Labia R; Morand A; Péduzzi J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene.
    Doran JL; Leskiw BK; Aippersbach S; Jensen SE
    J Bacteriol; 1990 Sep; 172(9):4909-18. PubMed ID: 2203736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli.
    Farrar WE; Newsome JK
    Am J Clin Pathol; 1976 Apr; 65(4):570-4. PubMed ID: 817594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):582-5. PubMed ID: 6255862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
    Jackson RT; Harris LF; Alford RH
    Antimicrob Agents Chemother; 1978 Jul; 14(1):118-25. PubMed ID: 356723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.
    Butterworth D; Cole M; Hanscomb G; Rolinson GN
    J Antibiot (Tokyo); 1979 Apr; 32(4):287-94. PubMed ID: 468715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins.
    Neu HC; Winshell EB
    Antimicrob Agents Chemother; 1972 Feb; 1(2):107-11. PubMed ID: 4218941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria.
    Farmer TH; Degnan BA; Payne DJ
    FEMS Microbiol Lett; 1999 Jul; 176(1):11-5. PubMed ID: 10418127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.
    Tzouvelekis LS; Tzelepi E; Mentis AF; Tsakris A
    J Antimicrob Chemother; 1993 May; 31(5):645-54. PubMed ID: 8335495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 39. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.